The Enterprise Value as of September 2024 (TTM) for Prime Medicine, Inc. (PRME) is 435.50M

According to Prime Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 435.50M. This represents a change of -41.53% compared to the average of 744.77M of the last 4 quarters.

Prime Medicine, Inc. (PRME) Historical Enterprise Value (quarterly & annually)

How has PRME Enterprise Value performed in the past?

The mean historical Enterprise Value of Prime Medicine, Inc. over the last ten years is 1.16B. The current 435.50M Enterprise Value has changed 3.67% with respect to the historical average. Over the past ten years (40 quarters), PRME's Enterprise Value was at its highest in in the September 2022 quarter at 1.43B. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.

Prime Medicine, Inc. (PRME) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Prime Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prime Medicine, Inc. (PRME) Average Enterprise Value

How has PRME Enterprise Value performed in the past?

The current Enterprise Value of Prime Medicine, Inc. (PRME) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Prime Medicine, Inc. (PRME) Enterprise Value vs. Peers

How is PRME’s Enterprise Value compared to its peers?

Prime Medicine, Inc.’s Enterprise Value is less than Beam Therapeutics Inc. (2.01B), greater than Caribou Biosciences, Inc. (172.45M), less than Intellia Therapeutics, Inc. (2.16B), less than Sana Biotechnology, Inc. (941.95M), greater than Reneo Pharmaceuticals, Inc. (11.36M), greater than Ginkgo Bioworks Holdings, Inc. (64.11M), greater than Ocean Biomedical, Inc. (45.32M), less than Royalty Pharma plc (18.53B), greater than Editas Medicine, Inc. (289.73M), less than CRISPR Therapeutics AG (3.82B), greater than Verve Therapeutics, Inc. (393.46M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (1.24B), greater than Century Therapeutics, Inc. (150.46M), less than Blueprint Medicines Corporation (6.15B),

Build a custom stock screener for Prime Medicine, Inc. (PRME) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prime Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prime Medicine, Inc. (PRME) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prime Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.